tiprankstipranks
Seres Therapeutics (MCRB)
NASDAQ:MCRB
US Market

Seres Therapeutics (MCRB) Income Statement

Compare
1,049 Followers

Seres Therapeutics Income Statement

Last quarter (Q3 2024), Seres Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Seres Therapeutics's net income was $88.78M. See Seres Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 126.33M$ 7.13M$ 144.93M$ 33.22M$ 34.51M
Gross Profit
$ 125.62M$ 6.12M$ 143.19M$ -57.35M$ -45.64M
Operating Expenses
$ 233.60M$ 253.62M$ 209.42M$ 121.34M$ 104.89M
Depreciation and Amortization
$ 6.24M$ 11.85M$ 9.22M$ 8.89M$ 9.83M
EBITDA
$ -94.31M$ -237.51M$ -56.72M$ -77.31M$ -59.95M
Operating Income
$ -107.98M$ -246.49M$ -64.49M$ -88.13M$ -71.88M
Other Income/Expenses
$ -5.74M$ -3.67M$ -1.08M$ -997.00K$ 1.60M
Pretax Income
$ -113.72M$ -250.16M$ -65.58M$ -89.13M$ -70.28M
Net Income
$ -113.72M$ -253.82M$ -61.50M$ -86.45M$ -64.24M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.89$ -2.35$ -0.67$ -1.08$ -1.13
Diluted EPS
$ -0.89$ -2.35$ -0.67$ -1.08$ -1.13
Weighted Average Shares Outstanding
128.00M 108.08M 91.70M 79.79M 56.65M
Weighted Average Shares Outstanding (Diluted)
128.00M 108.08M 91.70M 79.79M 56.65M
Currency in USD

Seres Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis